<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 15, 1998
ULTRAFEM, INC.
--------------
(Exact name of registrant as specified in its charter)
Delaware 0-27576 33-0435037
- ---------------------------- ------------------------ -------------------
(State or other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification No.)
130 West 42nd Street, Suite 1103, New York, New York 10036
-----------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (212) 921-2070
NOT APPLICABLE
-------------------------------------------------------------
(Former name or former address, if changed since last report)
<PAGE>
ITEM 5. OTHER EVENTS.
On May 15, 1998, Ultrafem, Inc. issued the press release (the "Press
Release") annexed as an exhibit hereto. The Press Release is incorporated
herein by reference.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(c) Exhibits.
99.4 Press Release of Ultrafem, Inc. dated May 15, 1998.
-2-
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
ULTRAFEM, INC.
(Registrant)
Dated: May 18, 1998 By: /s/ Dori M. Reap
--------------------------------------
Dori M. Reap
Office of the Chief Executive,
Senior Vice President, Finance and
Administration, Secretary and Chief
Financial Officer
By: /s/ Tonya G. Hinch
--------------------------------------
Tonya G. Hinch
Office of the Chief Executive,
Senior Vice President, Marketing
and Sales
-3-
<PAGE>
INDEX TO EXHIBITS
Exhibit No. Page No.
- ----------- --------
99.4 Press Release of Ultrafem, Inc. 5
dated May 15, 1998
-4-
<PAGE>
Exhibit No. 99.4
For Further Information,
Please Contact:
Ultrafem @ 212/921-2070
Dori Reap
Tonya Hinch
FOR IMMEDIATE RELEASE
ULTRAFEM ANNOUNCES DELISTING FROM NASDAQ
NEW YORK, NY, MAY 15, 1998 -- Ultrafem, Inc. announced today that
subsequent to its April 1, 1998 bankruptcy filing, NASDAQ notified the Company
on May 5, 1998 that Ultrafem common stock, which traded under the symbol UFEMQ,
was delisted from the Nasdaq National Market.
In unrelated matters, Richard Cone resigned from the Board of Directors on
April 30, 1998, according to Joy V. Jones, chairperson. The Company also
announced that two additional class action lawsuits have been filed against the
Company, certain of its officers, directors, and former directors. The Company
believes the allegations in these complaints are without merit. These actions
are stayed with respect to Ultrafem as a result of the Chapter 11 filing.
Ultrafem is a women's health care company. The Company's business strategy is
to develop, manufacture and market proprietary products based on its patented
SoftCup(R) technology.
* * * *
-5-
